Background Disease-modifying therapies (DMTs) for Alzheimer’s disease (AD) have early evidence of efficacy. Widespread delivery of DMTs will require major service reconfiguration. Treatment pathways ...

Introduction Short-term self-reported changes may be more strongly associated with long-term prognosis as they describe a disease trajectory and not a state. This study aimed to investigate the ...

Fifteen years ago, seeing a desperate need to preserve Dr. Gerson’s legacy and the progression of his therapy, Dr. Vickers created the Advanced Gerson Therapy Protocol and Clinic which, rapidly, ...